Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
We have a collection of glass smoking pipes for all.
Popular Articles

National All Schedules Prescription Electronic Reporting (NASPER) Act Receives Senate Support
The American Society of Interventional Pain Physicians (ASIPP) announced that the National All Schedules Prescription Electronic Reporting (NASPER) Act has received the support of Senator John D. Rockefeller IV of West Virginia and Senator Bob Corker of Tennessee.

This Time Around, Debate Much Different
Insurance companies, "the industry that gets credit for helping to kill the Clinton administration"s health care overhaul 15 years ago," are now "striking a conciliatory tone as it faces the most serious attempt to overhaul the system since that effort collapsed," CQ Politics reports. With low favorability ratings and Democrats in control of the federal government, "insurers know they aren"t in a good bargaining position" this time around. They have already offered concessions, including providing "insurance in the individual markets to everyone, without regard to who is sick," and not "charging people who are ill higher rates and cut health care costs." But they"ve also been ""careful to structure their offers in such a way that appears significant but does not overpromise." An individual mandate for all Americans and an end to health screening for applicants could offer "a win-win outcome, one that will benefit not just patients but potentially the profits of the industry as well." But "perhaps the biggest motivation for insurers to deal now is that they fear what might happen if they don"t" - the "creation of a government-run plan that would be more attractive to the public and siphon off customers" (Adams, 6/1).
News of the day
National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Infections
Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B. Savage of Brigham Young University, have demonstrated in a series of in vitro experiments and preclinical animal testing that an investigational drug compound known as CSA-13 shows promise as a potential therapy to treat viral infections from the vaccinia virus. The research appears ahead of print in an advanced online publication of the Journal of Investigate Dermatology, the official journal of the Society for Investigative Dermatology. This work was funded by the National Institute of Allergy and Infectious Diseases Atopic Dermatitis Vaccinia Network.
Cardiovascular

Fighting Human Trafficking By Genetic Identification

DNA-Prokids (http://www.dna-prokids.org), an international project on human trafficking prevention and fight using genetic identification of victims and their relatives, was officially presented, at the University of Granada (UGR) headquarters, in Spain. Traffic in human beings is one of the most frequent and profitable crimes at the beginning of the 21st century. According to data from the United Nations Office on Drugs and Crime (UNODC), approximately two million people are victims of human trafficking across the world. UN Secretary-General, Ban Ki-Moon, stated recently that "trafficking in weapons, drugs and blood diamonds has long been on the UN agenda" and that now is the time to "add people to that list". Upon suggestion of the UGR Genetic Identification Laboratory, an international project for genetic identification of missing children and their families was set up in 2004. The goal was to not limit the scope of research to domestic crimes, but to spread results worldwide with the aim of boosting the international fight against human trafficking. That was the start of DNA-Prokids, an initiative which has been praised by authorities and experts in genetic identification all over the world, and whose piloting experiences in countries such as Guatemala, Mexico, Philippines and Indonesia are being extremely successful. Goals The Head of the UGR Genetic Identification Laboratory, Prof. José A. Lorente, stressed that DNA-Prokids, as a programme for genetic identification of human trafficking victims and their relatives, serves "a triple objective: to hamper traffic in human beings thanks to identification of victims; to use such identification to return victims to their families (reunification), and to gather information on the origins, the routes and the means of this crime (police intelligence), key elements for the work of police forces and judicial systems". To date, there is no other specific initiative aimed at missing children identification based upon systematic and automatic international cooperation through a single worldwide database. This is exactly the mission of DNA-Prokids: coordinating, from both a scientific and a legal perspective, genetic identification protocols, a goal which scientists and authorities from Brazil, China, Colombia, Dubai, Guatemala, India, Indonesia, Malaysia, Mexico, Philippines, Spain, Thailand, USA or Venezuela have already expressed interest in. DNA-Prokids is an initiative of the UGR Genetic Identification Laboratory, in cooperation with the University of North Texas Center for Human Identification, in the USA, and with the contributions of financial institutions such as BBVA, FundaciÃön Botín (Banco Santander) or CajaGRANADA and of Life Technologies (USA). DNA-Prokids 1st International Conference Next October, the Southern Spanish city of Granada will host DNA-Prokids 1st International Conference: genetic identification against children trafficking. Scientists, NGOs, international bodies, representatives of security forces and experts from judicial systems will gather in this meeting with the aim of creating an international alliance against children trafficking by making the most of new genetic identification techniques. José Antonio Lorente Acosta University of Granada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009